BCAP29 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.888200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.695600E-01
Normal-vs-Stage2
8.422400E-01
Normal-vs-Stage3
6.364200E-01
Normal-vs-Stage4
4.873200E-01
Stage1-vs-Stage2
5.999600E-01
Stage1-vs-Stage3
7.147600E-01
Stage1-vs-Stage4
3.111000E-01
Stage2-vs-Stage3
4.137400E-01
Stage2-vs-Stage4
4.521000E-01
Stage3-vs-Stage4
2.122800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.028400E-01
Normal-vs-AfricanAmerican
4.899200E-01
Normal-vs-Asian
5.629000E-01
Caucasian-vs-AfricanAmerican
3.053400E-01
Caucasian-vs-Asian
2.209600E-01
AfricanAmerican-vs-Asian
8.536500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.457200E-01
Normal-vs-Female
8.153800E-01
Male-vs-Female
5.501600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.961600E-01
Normal-vs-Age(41-60Yrs)
4.820600E-01
Normal-vs-Age(61-80Yrs)
9.321400E-01
Normal-vs-Age(81-100Yrs)
6.697800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.403400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.922000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.111000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.183000E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.099900E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.610400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.516000E-01
Normal-vs-Daily Drinker
6.127000E-01
Normal-vs-Weekly Drinker
9.958800E-01
Normal-vs-Occasional Drinker
8.385000E-01
Normal-vs-Social Drinker
5.019600E-01
Non Drinker-vs-Daily Drinker
4.727800E-01
Non Drinker-vs-Weekly Drinker
8.953800E-01
Non Drinker-vs-Occasional Drinker
6.528800E-01
Non Drinker-vs-Social Drinker
1.398620E-01
Daily Drinker-vs-Weekly Drinker
3.372600E-01
Daily Drinker-vs-Occasional Drinker
1.655430E-01
Daily Drinker-vs-Social Drinker
4.655800E-02
Weekly Drinker-vs-Occasional Drinker
7.185200E-01
Weekly Drinker-vs-Social Drinker
1.763030E-01
Occasional Drinker-vs-Social Drinker
2.568600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.977800E-01
Normal-vs-Grade 2
4.957500E-02
Normal-vs-Grade 3
1.347440E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.202600E-03
Grade 1-vs-Grade 3
2.486400E-02
Grade 1-vs-Grade 4
2.977800E-01
Grade 2-vs-Grade 3
6.681200E-01
Grade 2-vs-Grade 4
4.957500E-02
Grade 3-vs-Grade 4
1.347440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.648400E-01
Normal-vs-NonDiabetic
9.437000E-01
Diabetic-vs-NonDiabetic
7.158200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.823200E-01
Normal-vs-NoPancreatitis
9.780400E-01
Pancreatitis-vs-NoPancreatitis
4.188800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.357400E-01
Normal-vs-N1
8.406000E-01
N0-vs-N1
7.329200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.342200E-01
Normal-vs-TP53-NonMutant
9.242000E-01
TP53-Mutant-vs-TP53-NonMutant
3.114800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
